Coccicure

Country: Eġittu

Lingwa: Ingliż

Sors: EDA (Egyptian Drug Authority)

Ingredjent attiv:

Sulphaquinoxaline sodium 150 mg Eq. to sulphaquinoxaline base 139.8 mg + Sulphadimidine sodium 70 mg Eq. to sulphadimidine base 64.9 mg + Sulphadiazine sodium 70 mg Eq. to sulphadiazine base 64.3 mg + Vitamin K3 2 mg + Vitamin A 8000 I.U. /1gm

Disponibbli minn:

Pharma Swede - Egypt

Għamla farmaċewtika:

Water Soluble Powder

Manifatturat minn:

Pharma Swede - Egypt

Similar products

Ingredjent attiv Sulphaquinoxaline sodium 150 mg Eq. to sulphaquinoxaline base 139.8 mg + Sulphadimidine sodium 70 mg Eq. to sulphadimidine base 64.9 mg + Sulphadiazine sodium 70 mg Eq. to sulphadiazine base 64.3 mg + Vitamin K3 2 mg + Vitamin A 8000 I.U. /1gm

Sulphaquinoxaline sodium 150 mg Eq. to sulphaquinoxaline base 139.8 mg + Sulphadimidine sodium 70 mg Eq. to sulphadimidine base 64.9 mg + Sulphadiazine sodium 70 mg Eq. to sulphadiazine base 64.3 mg + Vitamin K3 2 mg + Vitamin A 8000 I.U. /1gm

Marketed minn Pharma Swede - Egypt

Pharma Swede - Egypt

Fittex twissijiet relatati ma 'dan il-prodott

Twissijiet Coccicure Sulphaquinoxaline sodium 150 Eq.

Coccicure Sulphaquinoxaline sodium 150 Eq.

Ara l-istorja tad-dokumenti

L-istorja tad-dokumenti L-istorja tad-dokumenti

Coccicure